Clinical trial
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)
NCT00474370 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00474370 |
|---|---|
| Title | Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) |
| Official title | Vicriviroc in Combination Treatment With an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Acquired Immunodeficiency Syndrome |
| Intervention type | Drug |
| Interventions | Vicriviroc, Placebo |
| Enrollment | 400 |
| Start date | May 15, 2007 |
| Primary completion | Aug 24, 2009 |
| Completion | Oct 26, 2010 |
| First posted | May 16, 2007 |
| Last update posted | Aug 30, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: